AMERIPRISE FINANCIAL INC

Holdings History for BIOMARIN PHARMACEUTICAL INC - NOTE 0.599% 8/0

Investment type: Debt / NOTE 0.599% 8/0

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Principal	Change	Activity %	Price	All Holders
31 Mar 2023		-0%	$0	0	-15,000	-100%		Q1 2023
31 Dec 2022	0%	+0%	$16,000	15,000	+15,000	NEW	106.67%	Q4 2022
31 Dec 2019		-0.01%	$0	0	-11,503,000	-100%		Q4 2019
30 Sep 2019	0.01%	+0%	$11,307,000	11,503,000	+3,000	+0.03%	98.3%	Q3 2019
30 Jun 2019	0.01%	0%	$11,938,000	11,500,000	0		103.81%	Q2 2019
31 Mar 2019	0.01%	0%	$11,766,000	11,500,000	0		102.31%	Q1 2019
31 Dec 2018	0.01%	+0.01%	$11,436,000	11,500,000	+11,500,000	NEW	99.44%	Q4 2018

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.